First case of rare blood-clotting condition linked to J&J COVID-19 vaccine diagnosed in Utah –

SALT LAKE CITY– The first case of a rare blood-clotting condition believed to be linked to the Johnson & & Johnson COVID-19 vaccine has actually been identified in Utah.A male client was recently identified with vaccine-induced Thrombotic Thrombocytopenia, also understood as VITT, at the University of Utah Hospital, U. health officials stated in a Wednesday news release.The client, who is under the age of 50, was dealt with and is now recuperating at house, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah.” He continues to do well and feel well,” Abou-Ismail stated at a Wednesday news conference about the case.The blood embolisms condition led to a nationwide pause on administration of the Johnson & & Johnson vaccine last month after six cases were reported amongst over 6 million individuals who received the vaccine. Doctors followed up with him several days back and he continues to enhance, Abou-Ismail said.So far, the Centers for Disease Control and Prevention has verified 17 cases of VITT in the United States believed to be linked to the Johnson & & Johnson vaccine out of about 8 million doses administered, according to Abou-Ismail.